Results overview: Found 3 records in 0.02 seconds.
Articles, 2 records found
Research literature, 1 records found
Articles 2 records found  
1.
11 p, 635.6 KB P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gp high cells and correlates with HIV-1 viral load / Minuesa Dinarés, Gerard (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Arimany-Nardi, Cristina (National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos III) ; Erkizia, Itziar (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Cedeño, Samandhy (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Moltó Marhuenda, José (Institut Germans Trias i Pujol. Fundació de Lluita contra la Sida) ; Clotet, Bonaventura (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Pastor-Anglada, Marçal (National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos III) ; Martínez Picado, Francisco Javier (Universitat de Vic, Universitat Central de Catalunya (UVic-UCC))
To evaluate the role of P-glycoprotein (P-gp) and multidrug-resistant-protein 1 (MRP1) on raltegravir intracellular drug disposition in CD4+ T cells, investigate the effect of HIV-1 infection on P-gp expression and correlate HIV-1 viraemia with P-gp activity in primary CD4+ T cell subsets. [...]
2016 - 10.1093/jac/dkw215
Journal of Antimicrobial Chemotherapy, Vol. 71 (june 2016) , p. 2782-2792  
2.
10 p, 1.6 MB Etravirine pharmacokinetics in HIV-infected pregnant women / Mulligan, Nikki (University of California (Estats Units d'Amèrica)) ; Schalkwijk, Stein (Radboud University Nijmegen Medical Centre (Nijmegen, Països Baixos)) ; Best, Brookie M. (University of California (Estats Units d'Amèrica)) ; Colbers, Angela (Radboud University Nijmegen Medical Centre (Nijmegen, Països Baixos)) ; Wang, Jiajia (Harvard School of Public Health (Boston, Estats Units d'Amèrica)) ; Capparelli, Edmund V. (University of California (Estats Units d'Amèrica)) ; Moltó Marhuenda, José ((Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Stek, Alice M. (University of Southern California. School of Medicina (Estats Units d'Amèrica)) ; Taylor, Graham (Imperial College Healthcare National Health Service Trust (Londres, Regne Unit)) ; Smith, Elizabeth (National Institute of Allergy and Infectious Diseases (Bethesda, Estats Units d'Amèrica)) ; Hidalgo Tenorio, Carmen (Hospital Virgen de las Nieves (Granada, Andalusia)) ; Chakhtoura, Nahida (Eunice Kennedy Shriver National Institute of Child Health and Human Development (Bethesda, Estats Units d'Amèrica)) ; Van Kasteren, Marjo (Saint Elisabeth Hospital (Tilburg, Països Baixos)) ; Fletcher, Courtney V. (University of Nebraska Medical Center (Omaha, Estats Units d'Amèrica)) ; Mirochnick, Mark (Boston University School of Medicine (Estats Units d'Amèrica)) ; Burger, David (Radboud University Nijmegen Medical Centre (Nijmegen, Països Baixos)) ; PANNA Network ; IMPAACT Network
BACKGROUND: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women. METHODS: IMPAACT P1026s and PANNA are on-going, non-randomized, open-label, parallel-group, multi-center phase-IV prospective studies in HIV-infected pregnant women. [...]
2016 - 10.3389/fphar.2016.00239
Frontiers in Pharmacology, Vol. 7 Núm. 239 (August 2016)  

Research literature 1 records found  
1.
218 p, 1.4 MB Farmacocinética poblacional de Lopinavir y Ritonavir en pacientes adultos infectados por el VIH / Moltó Marhuenda, José ; Clotet i Sala, Bonaventura, dir. (Hospital Germans Trias i Pujol) ; Valle Cano, Marta, dir. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona. Departament de Farmacologia i de Terapèutica i de Toxicologia
Objetivos: 1. - Determinar la variabilidad interindividual de la concentración valle en plasma de los fármacos inhibidores de la transcriptasa inversa no análogos de los nucleósidos (ITINAN) y de los inhibidores de la proteasa (IP) del virus de la inmunodeficiencia humana (VIH), así como la proporción de pacientes infectados por el VIH en tratamiento antirretroviral con concentraciones valle de los fármacos por debajo de la concentración mínima eficaz en la practica clínica habitual. [...]
Objectives: 1. - To assess interindividual variability in trough concentrations in plasma of non-nucleoside reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI) among HIV-infected adults as well as the proportion of patients with drug concentrations below the proposed minimum effective concentration in an outpatient routine clinical practice setting. [...]

Bellaterra : Universitat Autònoma de Barcelona, 2010  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.